Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on January 18, 2007

Stroke. 2007
Published online before print January 18, 2007, doi: 10.1161/01.STR.0000254524.23708.c9
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/2/431    most recent
01.STR.0000254524.23708.c9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khatri, P.
Right arrow Articles by Broderick, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khatri, P.
Right arrow Articles by Broderick, J. P.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Emergency treatment of Stroke
Right arrow Intracerebral Hemorrhage
Right arrow Thrombolysis
Right arrow Other Stroke Treatment - Medical
Right arrow Other Stroke Treatment - Surgical

Submitted on August 14, 2006
Revised on September 17, 2006
Accepted on September 20, 2006

Intracranial Hemorrhage Associated With Revascularization Therapies

Pooja Khatri MD*; Lawrence R. Wechsler MD; and Joseph P. Broderick MD

From University of Cincinnati (P.K., J.P.B.), Department of Neurology, Cincinnati, Ohio; and the University of Pittsburgh (L.R.W.), Pa.

* To whom correspondence should be addressed. E-mail: pooja.khatri{at}uc.edu.

Background and Purpose--This review discusses the state of our current knowledge on hemorrhagic transformation (HT) and summarizes key factors to be considered when comparing risk associated with various approaches to revascularization.

Summary of Review--HT is a common and natural consequence of infarction, likely related to matrix metalloproteinases and free radical pathways disrupting permeability barriers between blood and brain during ischemia and reperfusion. Symptomatic HT rates within 24 to 36 hours of stroke are increased in the setting of revascularization therapy regardless of modality. HT incidence rates must be considered in the context of the timing of imaging, the period of the study, the definition of clinically significant HT, and other key predictors of HT. The most consistently identified predictors of clinically significant HT in acute revascularization trials have been thrombolytic therapy, dose of lytic agents, edema or mass effect on head CT, stroke severity, and age. Other risk factors may be hyperglycemia, concurrent heparin use, timing of therapy, and timing of successful recanalization. Future predictors may also include imaging parameters, serological markers, variables related to intra-arterial technique, and arterial lesion location.

Conclusions--Understanding how baseline and treatment variables impact HT rates after acute stroke is critical for those designing and interpreting acute stroke trials. Future trials should consider the use of PH-2 as a standardized safety end point, putting hemorrhagic changes in the context of overall clinical outcome, and developing strategies to reduce the rates of clinically significant intracranial hemorrhage.


Key words: stroke • ischemia • reperfusion • thrombolysis • endovascular treatment • intracranial hemorrhage




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A. Bose, H. Henkes, K. Alfke, W. Reith, T.E. Mayer, A. Berlis, V. Branca, S. P. Sit, and for the Penumbra Phase 1 Stroke Trial Investigator
The Penumbra System: A Mechanical Device for the Treatment of Acute Stroke due to Thromboembolism
AJNR Am. J. Neuroradiol., August 1, 2008; 29(7): 1409 - 1413.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Khatri, S. E. Kasner, and D. Kolansky
Reply
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 317 - 318.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Khatri, R. A. Taylor, V. Palumbo, V. Rajajee, J. M. Katz, J. A. Chalela, A. Geers, J. Haymore, D. M. Kolansky, S. E. Kasner, et al.
The safety and efficacy of thrombolysis for strokes after cardiac catheterization.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. B. van der Worp and J. van Gijn
Acute Ischemic Stroke
N. Engl. J. Med., August 9, 2007; 357(6): 572 - 579.
[Full Text] [PDF]


Home page
StrokeHome page
J. L. Saver
Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke, August 1, 2007; 38(8): 2279 - 2283.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. M. Demaerschalk
Thrombolytic Therapy for Acute Ischemic Stroke: The Likelihood of Being Helped Versus Harmed
Stroke, August 1, 2007; 38(8): 2215 - 2216.
[Full Text] [PDF]